Trial · NCT06668922
Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
The study will investigate the relationship between fecal bile acids, short-chain fatty acids (SCFAs), and the gut microbiota in irritable bowel syndrome (IBS).
- Status
- Recruiting
- Sponsor
- University of California, Los Angeles
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 72 participants (planned)
- Start
- Nov 28, 2024
- Primary completion
- Dec 31, 2029
- Conditions
- Irritable Bowel Syndrome (IBS)
Summary
The study will investigate the relationship between fecal bile acids, short-chain fatty acids (SCFAs), and the gut microbiota in irritable bowel syndrome (IBS). The central hypothesis of this study is that specific shifts in the GI microbiome composition correlate with altered colonic SCFAs and BAs and contribute to IBS symptoms.
Interventions
- Inulin Dietary supplement
Locations
1 country: United States.
| Facility | City | Country |
|---|---|---|
| University of California, Los Angeles | Los Angeles, California | United States |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.